It's How Medicine Should Be®

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Michael J. Liptay, MD

Patient Feedback
  • Thoracic and Cardiac Surgery
  • Surgery
Board Certification:
  • Thoracic and Cardiac Surgery
  • Surgery
Faculty Rank: Professor
Medical or Graduate Education: Northwestern University Feinberg School of Medicine
Residency: Barnes-Jewish Hospital - Surgery
Fellowship: Brigham and Women's Hospital - Thoracic Surgery
Clinical Expertise:
  • Cancer surgery, lung
  • Chest tumors
  • Esophageal cancer
  • Esophagectomy
  • Esophagus disorders
  • Hyperhidrosis
  • Lung cancer
  • Thoracic surgery
  • Thoracoscopic surgery
  • Video-assisted thoracoscopic surgery (VATS)
Research Interests:
  • Lung cancer
  • Micrometastases
  • Molecular profiling
  • Proteomics
Google Map
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. 50th Anniversary Landmark Commentary on Jensik RJ, Faber LP, Kittle CF. Segmental resection for bronchogenic carcinoma. Ann Thorac Surg 1979;28:475-83.
    Liptay MJ
    Ann. Thorac. Surg.
    2015 Sep
  2. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
    Ziel E, Hermann G, Sen N, Bonomi P, Liptay MJ, Fidler MJ, Batus M, Warren WH, Chmielewski G, Sher DJ
    J Thorac Oncol
    2015 Oct
  3. Smaller incisions for smaller cancers.
    Liptay MJ
    Oncology (Williston Park, N.Y.)
    2015 Mar
    29(3):166; 168.
  4. Early pneumonectomy for pulmonary mucormycosis.
    Vercillo MS, Liptay MJ, Seder CW
    Ann. Thorac. Surg.
    2015 Mar
  5. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.
    Sher DJ, Fidler MJ, Seder CW, Liptay MJ, Koshy M
    Int. J. Radiat. Oncol. Biol. Phys.
    2015 Jun 1
  6. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
    Sher DJ, Fidler MJ, Liptay MJ, Koshy M
    Lung Cancer
    2015 Jun
  7. Status of sentinel lymph node mapping in non-small cell lung cancer.
    Shersher DD, Liptay MJ
    Cancer J
    2015 Jan-Feb
  8. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
    Seder CW, Kubasiak JC, Pithadia R, Basu S, Fhied C, Tarhoni I, Davila E, Alnajjar H, Chmielewski GW, Warren WH, Liptay MJ, Borgia JA
    Ann. Thorac. Surg.
    2015 Aug
  9. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
    Kubasiak JC, Seder CW, Pithadia R, Basu S, Fhied C, Phillips WW, Daly S, Shersher DD, Yoder MA, Chmielewski G, Edell ES, Maldonado F, Liptay MJ, Borgia JA
    J. Thorac. Cardiovasc. Surg.
    2014 Sep 19
  10. Circulating Angiogenesis Biomarkers Are Associated With Disease Progression in Lung Adenocarcinoma.
    Daly S, Kubasiak JC, Rinewalt D, Pithadia R, Basu S, Fhied C, Lobato GC, Seder CW, Hong E, Warren WH, Chmielewski G, Liptay MJ, Bonomi P, Borgia JA
    Ann. Thorac. Surg.
    2014 Oct 6
  11. Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution.
    Sher DJ, Liptay MJ, Fidler MJ
    Int. J. Radiat. Oncol. Biol. Phys.
    2014 Jun 1
  12. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ, Koshy M, Liptay MJ, Fidler MJ
    2014 Apr 1
  13. Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection.
    Garg S, Gielda BT, Turian JV, Liptay M, Warren WH, Bonomi P, Sher DJ
    Pract Radiat Oncol
    2013 Oct-Dec
  14. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S, Rinewalt D, Fhied C, Basu S, Mahon B, Liptay MJ, Hong E, Chmielewski G, Yoder MA, Shah PN, Edell ES, Maldonado F, Bungum AO, Borgia JA.
    J Thorac Oncol. 2013
    2013 Jan
    8(1):31-6. doi: 10.1097/JTO.0b013e31827627f8.
  15. Multimodality treatment of pleural mesothelioma.
    Shersher DD, Liptay MJ.
    Surg Oncol Clin N Am. 2013
    2013 Apr
    22(2):345-55. doi: 10.1016/j.soc.2012.12.004. Epub 2012 Dec 29.
  16. Esophageal carcinoma advances in treatment results for locally advanced disease: review.
    Herskovic A, Russell W, Liptay M, Fidler MJ, Al-Sarraf M.
    Ann Oncol.
    2012 May
  17. Anterior mediastinal mass secondary to histoplasmosis.
    Shersher DD, Hong E, Breard J, Warren WH, Liptay MJ.
    Ann Thorac Surg. 2012
    2012 Jan
    93(1):e9-10. doi: 10.1016/j.athoracsur.2011.07.093.
  18. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P.
    Clin Lung Cancer. 2012
    2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print]
  19. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
    Bradly DP, Gattuso P, Pool M, Basu S, Liptay M, Bonomi P, Buckingham L.
    Diagn Mol Pathol. 2012
    2012 Dec
    21(4):207-13. doi: 10.1097/PDM.0b013e31825554b2.
  20. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients.
    Rinewalt D, Shersher DD, Daly S, Fhied C, Basu S, Mahon B, Hong E, Chmielewski G, Liptay MJ, Borgia JA.
    J Thorac Cardiovasc Surg. 2012
    2012 Dec
    144(6):1344-50; discussion 1350-1. doi: 10.1016/j.jtcvs.2012.08.033. Epub 2012 Sep 13.
  21. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
    Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP.
    Int J Radiat Oncol Biol Phys. 2011
    2011 Nov 15
    81(4):985-91. doi: 10.1016/j.ijrobp.2010.06.059. Epub 2010 Oct 6.
  22. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer.
    Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, Bonomi P, Liptay MJ, Borgia JA.
    Ann Thorac Surg. 2011
    2011 Nov
    92(5):1805-11; discussion 1811. doi: 10.1016/j.athoracsur.2011.06.058. Epub 2011 Sep 25.
  23. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
    Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P.
    J Thorac Oncol. 2011
    2011 Jun
    6(6):1079-86. doi: 10.1097/JTO.0b013e3182199a7c.
  24. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
    Patel K, Farlow EC, Kim AW, Lee BS, Basu S, Coon JS, DeCresce D, Thimothy L, Walters KA, Fhied C, Chang C, Chen SH, Faber LP, Bonomi P, Liptay MJ, Borgia JA.
    Int J Cancer. 2011
    2011 Jul 1
    129(1):133-42. doi: 10.1002/ijc.25644. Epub 2010 Nov 9.
  25. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW, Liptay MJ, Bonomi P, Warren WH, Basu S, Farlow EC, Faber LP.
    Ann Thorac Surg. 2011
    2011 Jul
    92(1):233-41; discussion 241-3. doi: 10.1016/j.athoracsur.2011.03.001. Epub 2011 May 28.
  26. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
    Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ.
    Lung Cancer. 2011
    2011 Feb
    71(2):186-90. doi: 10.1016/j.lungcan.2010.05.006. Epub 2010 Jun 8.
  27. Adenocarcinoma in a 40-year-old colonic interposition treated with Ivor Lewis esophagectomy and esophagogastric anastomosis.
    Shersher DD, Hong E, Warren W, Penfield Faber L, Liptay MJ.
    Ann Thorac Surg. 2011
    2011 Dec
    92(6):e113-4. doi: 10.1016/j.athoracsur.2011.06.025.
  28. The early years: how to set up and build your practice.
    Liptay MJ.
    Thorac Surg Clin. 2011
    2011 Aug
    21(3):341-7. doi: 10.1016/j.thorsurg.2011.04.002.
  29. STS database risk models: predictors of mortality and major morbidity for lung cancer resection.
    Kozower BD, Sheng S, O'Brien SM, Liptay MJ, Lau CL, Jones DR, Shahian DM, Wright CD.
    Ann Thorac Surg. 2010
    2010 Sep
    90(3):875-81; discussion 881-3. doi: 10.1016/j.athoracsur.2010.03.115.
  30. A multi-analyte serum test for the detection of non-small cell lung cancer
    Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, Warren WH, Bonomi P, Liptay MJ, Borgia JA
    Br J Cancer
    2010 Oct 12
  31. Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival.
    Kim AW, Faber LP, Warren WH, Shah ND, Basu S, Liptay MJ.
    J Thorac Cardiovasc Surg. 2010
    2010 Mar
    139(3):606-11. doi: 10.1016/j.jtcvs.2009.05.044. Epub 2009 Aug 25.
  32. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
    Farlow EC, Patel K, Basu S, Lee BS, Kim AW, Coon JS, Faber LP, Bonomi P, Liptay MJ, Borgia JA.
    Clin Cancer Res. 2010
    2010 Jul 1
    16(13):3452-62. doi: 10.1158/1078-0432.CCR-09-3192. Epub 2010 Jun 22.
  33. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
    Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, Fidler M, Walters K, Bonomi P, Coon J.
    Int J Cancer. 2010
    2010 Apr 1
    126(7):1630-9. doi: 10.1002/ijc.24896.
  34. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy.
    Hollings DD, Higgins RS, Faber LP, Warren WH, Liptay MJ, Basu S, Kim AW.
    Am J Surg. 2010
    2010 Apr
    199(4):558-61. doi: 10.1016/j.amjsurg.2009.11.006.
  35. Sentinel node mapping in lung cancer: introduction.
    Liptay MJ.
    Semin Thorac Cardiovasc Surg. 2009
    2009 Winter
    21(4):297. doi: 10.1053/j.semtcvs.2009.12.001. No abstract available.
  36. Right middle lobectomy for a primary pulmonary leiomyoma: a case report.
    Vercillo MS, Kim AW, Pitelka L, Gattuso P, Liptay MJ.
    Cases J. 2009
    2009 Sep 8
    2:8673. doi: 10.1186/1757-1626-0002-0000008673.
  37. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.
    Ann Thorac Surg. 2009
    2009 Sep
    88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084.
  38. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does side really matter?
    Kim AW, Faber LP, Warren WH, Basu S, Wightman SC, Weber JA, Bonomi P, Liptay MJ.
    Ann Thorac Surg. 2009
    2009 Sep
    88(3):937-43; discussion 944. doi: 10.1016/j.athoracsur.2009.04.102.
  39. An unusual case of Aspergillus fibrosing mediastinitis.
    Wightman SC, Kim AW, Proia LA, Faber LP, Gattuso P, Warren WH, Liptay MJ.
    Ann Thorac Surg. 2009
    2009 Oct
    88(4):1352-4. doi: 10.1016/j.athoracsur.2009.02.087.
  40. Enucleation of a giant esophageal gastrointestinal stromal tumor.
    Milman S, Kim AW, Farlow E, Liptay MJ.
    Ann Thorac Surg. 2009
    2009 May
    87(5):1603-5. doi: 10.1016/j.athoracsur.2008.09.010.
  41. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA, Basu S, Faber LP, Kim AW, Coon JS, Kaiser-Walters KA, Fhied C, Thomas S, Rouhi O, Warren WH, Bonomi P, Liptay MJ.
    J Thorac Oncol. 2009
    2009 Mar
    4(3):338-47. doi: 10.1097/JTO.0b013e3181982abf.
  42. Simultaneous costal cartilage-sparing modified Ravitch procedure and latissimus dorsi transfer for chest wall deformity repair in Poland's syndrome.
    Dingeldein MW, Lu CY, Kim AW, Ostric S, Liptay MJ, Holterman MJ.
    J Pediatr Surg. 2009
    2009 Jan
    44(1):e29-32. doi: 10.1016/j.jpedsurg.2008.10.068.
  43. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.
    Liptay MJ, D'amico TA, Nwogu C, Demmy TL, Wang XF, Gu L, Litle VR, Swanson SJ, Kohman LJ; Thoracic Surgery Subcommittee of the Cancer and Leukemia Group B.
    J Thorac Oncol. 2009
    2009 Feb
    4(2):198-202. doi: 10.1097/JTO.0b013e318194a2c3.
  44. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.
    Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, Hammoud ZT, Kim AW.
    J Surg Oncol. 2009
    2009 Dec 15
    100(8):703-7. doi: 10.1002/jso.21407.
  45. Cytologic features of adult spindle cell variant of rhabdomyosarcoma: a report of two cases.
    Patel A, Placido JB, Pitelka L, Gattuso P, Liptay M, Kim A.
    Diagn Cytopathol. 2009
    2009 Dec
    37(12):932-4. doi: 10.1002/dc.21189. No abstract available.
  46. Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies.
    Kim AW, Liptay MJ, Saclarides TJ, Warren WH.
    Interact Cardiovasc Thorac Surg. 2009
    2009 Aug
    9(2):379-81. doi: 10.1510/icvts.2009.207555. Epub 2009 May 8.
  47. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial.
    Kim AW, Faber LP, Warren WH, Saclarides TJ, Carhill AA, Basu S, Choh MS, Liptay MJ.
    Surgery. 2008
    2008 Oct
    144(4):712-7; discussion 717-8. doi: 10.1016/j.surg.2008.07.007. Epub 2008 Aug 29.
  48. Contemporary review on the inequities in the management of lung cancer among the African-American population.
    Kim AW, Liptay MJ, Higgins RS.
    J Natl Med Assoc. 2008
    2008 Jun
    100(6):683-8. Review.
  49. Utility of silicone esophageal bypass stents in the management of delayed complex esophageal disruptions.
    Kim AW, Liptay MJ, Snow N, Donahue P, Warren WH.
    Ann Thorac Surg. 2008
    2008 Jun
    85(6):1962-7; discussion 1967. doi: 10.1016/j.athoracsur.2008.02.043.
  50. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion
    Warren WH, Kim AW, Liptay MJ
    Eur J Cardiothorac Surg
    2008 Jan
  51. Sentinel node mapping in lung cancer: the Holy Grail?
    Liptay MJ.
    Ann Thorac Surg. 2008
    2008 Feb
    85(2):S778-9. doi: 10.1016/j.athoracsur.2007.10.103. Review. No abstract available.
  52. Cytologic imprints of giant atypical bronchopulmonary carcinoid tumor of the lung with extensive oncocytic component.
    McIntire M, Shah ND, Kim AW, Gattuso P, Liptay MJ.
    Diagn Cytopathol. 2008
    2008 Dec
    36(12):887-90. doi: 10.1002/dc.20946.
  53. Invited commentary.
    Liptay MJ.
    Ann Thorac Surg. 2008
    2008 Aug
    86(2):395. doi: 10.1016/j.athoracsur.2008.05.067. No abstract available.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.